SM
Sabby Management’s Phio Pharmaceuticals PHIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-25,131
| Closed | -$86.7K | – | 29 |
|
|
2024
Q3 | $86.7K | Buy |
+25,131
| New | +$86.7K | 0.05% | 14 |
|
|
2024
Q1 | – | Sell |
-172,693
| Closed | -$131K | – | 62 |
|
|
2023
Q4 | $131K | Buy |
172,693
+16,654
| +11% | +$12.7K | 0.13% | 25 |
|
|
2023
Q3 | $236K | Sell |
156,039
-713
| -0.5% | -$1.08K | 0.17% | 25 |
|
|
2023
Q2 | $450K | Buy |
+156,752
| New | +$450K | 0.37% | 26 |
|
|
2021
Q4 | – | Sell |
-40,684
| Closed | -$83K | – | 127 |
|
|
2021
Q3 | $83K | Sell |
40,684
-11,072
| -21% | -$22.6K | 0.01% | 85 |
|
|
2021
Q2 | $117K | Buy |
51,756
+28,749
| +125% | +$65K | 0.02% | 78 |
|
|
2021
Q1 | $62K | Buy |
+23,007
| New | +$62K | 0.01% | 80 |
|
|
2020
Q2 | – | Sell |
-255,194
| Closed | -$452K | – | 74 |
|
|
2020
Q1 | $452K | Buy |
+255,194
| New | +$452K | 0.19% | 21 |
|
|
2019
Q1 | – | Sell |
-1,575,157
| Closed | -$520K | – | 80 |
|
|
2018
Q4 | $520K | Buy |
+1,575,157
| New | +$520K | 0.11% | 30 |
|
|
2018
Q3 | – | Sell |
-168,462
| Closed | -$325K | – | 98 |
|
|
2018
Q2 | $325K | Buy |
+168,462
| New | +$325K | 0.05% | 50 |
|
|
2017
Q1 | – | Sell |
-397,371
| Closed | -$284K | – | 172 |
|
|
2016
Q4 | $284K | Buy |
+397,371
| New | +$284K | 0.02% | 112 |
|